{"id":"W2800919475","doi":"10.1212/wnl.88.16_supplement.p6.384","title":"Number Needed to Treat Analyses to Assess Clinical Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Alemtuzumab or Ocrelizumab (P6.384)","year":2017,"lang":"en","type":"article","venue":"Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Ocrelizumab; Relapsing remitting; Alemtuzumab; Multiple sclerosis; Medicine; Fingolimod; Freedman; Internal medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05777739,0.002705034,0.008276375,0.002828436,0.0006944213,0.001423918,0.00206145,0.002327745,0.01015957],"category_scores_gemma":[0.05186049,0.0007161003,0.01726536,0.001649346,0.001227434,0.003048735,0.001890492,0.005687336,0.0004071304],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001508179,"about_ca_system_score_gemma":0.001203821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007977399,"about_ca_topic_score_gemma":0.001160481,"domain_scores_codex":[0.9264116,0.06019264,0.004060519,0.003893571,0.003954113,0.001487574],"domain_scores_gemma":[0.9537061,0.03826578,0.004086283,0.002179376,0.001129304,0.0006332213],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.554356,0.002053399,0.04393417,0.0165451,0.2925795,0.0008579317,0.0005041337,0.007834076,0.003029569,0.004084433,0.01639782,0.0578238],"study_design_scores_gemma":[0.2352229,0.09333802,0.1925891,0.0040338,0.2517697,0.002457889,0.001136365,0.1046288,0.01219625,0.03643719,0.06540936,0.000780522],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.686507,0.09724458,0.1162101,0.004999253,0.01433433,0.02920618,0.02408449,0.001549659,0.02586445],"genre_scores_gemma":[0.9181658,0.002706341,0.03578636,0.002991438,0.0009582869,0.02679665,0.005209811,0.0003608696,0.007024386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05777739,"threshold_uncertainty_score":0.3055597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2428046097930398,"score_gpt":0.4328344699699672,"score_spread":0.1900298601769274,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}